Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy
Amira Zaher, Laura Stephens, Ann M. Miller, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12

Showing 12 citing articles:

Empowering γδ T‐cell functionality with vitamin C
Dieter Kabelitz, Lea Cierna, Claudia Juraske, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 7
Open Access | Times Cited: 4
Pharmacological Ascorbate Combined with Rucosopasem Selectively Radio-chemo-sensitizes NSCLC via Generation of H2O2
Casey Pulliam, Melissa A. Fath, Sho S, et al.
Redox Biology (2025) Vol. 80, pp. 103505-103505
Open Access
Review of the Potential Role of Ascorbate in the Prevention and Treatment of Gynecological Cancers
Xiaochang Shen, Jiandong Wang, Boer Deng, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 617-617
Open Access | Times Cited: 3
Arenobufagin enhances T-cell anti-tumor immunity in colorectal cancer by modulating HSP90β accessibility
Zhihao Shang, Yiping Fan, Xi Songyang, et al.
Phytomedicine (2024) Vol. 128, pp. 155497-155497
Open Access | Times Cited: 2
Non-pharmaceutical interventions to optimize cancer immunotherapy
Maximilian Boesch, Florent Baty, Frank Rassouli, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Differential H2O2 Metabolism among Glioblastoma Subtypes Confers Variable Responses to Pharmacological Ascorbate Therapy Combined with Chemoradiation
Amira Zaher, Kranti A. Mapuskar, Jann N. Sarkaria, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17158-17158
Open Access | Times Cited: 4
High-dose vitamin C as a metabolic treatment of cancer: a new dimension in the era of adjuvant and intensive therapy
Xin Wang, Jia He, Minmin Sun, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy
Angela Lauriola, Pierpaola Davalli, Gaetano Marverti, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 3009-3009
Open Access | Times Cited: 3
Pembrolizumab plus Pharmacologic Ascorbate in the Treatment of Leiomyosarcoma
John Rieth, Alex Belzer, Mackenzie L. Walhof, et al.
Case Reports in Oncology (2024) Vol. 17, Iss. 1, pp. 906-912
Open Access
Pembrolizumab plus pharmakologisches Ascorbat zur Behandlung des Leiomyosarkoms
John Rieth, Alex Belzer, Mackenzie L. Walhof, et al.
Kompass Onkologie (2024), pp. 1-4
Closed Access
Long-term tumor suppression in cholangiocarcinoma using cytokine-induced killer cell therapy and high-dose vitamin C: a case report
Kang-Seok Kim, H. Wang, Jiewon Lee, et al.
Korean Journal of Clinical Oncology (2024) Vol. 20, Iss. 2, pp. 84-87
Closed Access
Crosstalk between gut microbiota and tumor: tumors could cause gut dysbiosis and metabolic imbalance
Siyuan Zhang, Haimei Wen, Ying Chen, et al.
Molecular Oncology (2024)
Open Access
Page 1

Scroll to top